Opinion: My aunt’s ‘Kafkaesque journey’ to get the home care she needed
As an attorney who has concentrated in elder law and long-term care rights for more…
Author: STAT
Opinion: Expanding the domestic public health supply chain is a matter of national security
One of the many hard lessons learned from Covid-19 has been that a robust and…
.jpg)
STAT+: The Theranos scandal cast a pall over self-testing. The pandemic is giving the industry another shot
This could have been Elizabeth Holmes’ moment. When the then-19-year-old founded Theranos in 2003, she…
STAT+: Sesen Bio pulls E.U. application for FDA-rejected cancer drug
Sesen Bio, a small biotech firm whose investigational cancer treatment once seemed poised for approval,…
Mental health giants Headspace and Ginger to merge into $3 billion company
Headspace and Ginger, two of the most prominent companies in the increasingly competitive mental health…
STAT+: Pharmalittle: Second J&J vaccine dose boosts antibodies against Covid; age lowered for diabetes screening
Good morning! Katie Palmer here, tagging in for Ed Silverman as he embraces the final…
Opinion: Listen: A father describes the legacy of his son’s ultra-rare disease
Bertrand Might was born with a rare disease that had never before been diagnosed, an…
Opinion: New antivirals are sorely needed. A public-private partnership can get us there
The U.S. government’s announcement that it is investing $3 billion into research on antiviral medicines…
Opinion: Ivermectin for Covid-19: abundance of hype, dearth of evidence
Here’s a tip for navigating the constantly evolving data on treatments for Covid-19: Beware when…
The WHO is looking for experts to help investigate the origins of pathogens — including the coronavirus
The Covid-19 pandemic has elevated scrutiny over how pathogens leap into humans like no crisis…
Covid-19 vaccines flirted with perfection at first. Reality is more complicated
When Covid-19 vaccines were reported last fall to be roughly 95% effective at preventing symptomatic…
As Delta spread, Covid-19 vaccine effectiveness against infection fell from 90% to 66% in one key study
The effectiveness of Covid-19 vaccines at preventing infection fell in one study of U.S. frontline…
As diabetes prevalence rises in children and adults, screening age drops to 35 for overweight adults
The age at which adults who are overweight or obese should be screened for type…
Opinion: Florida doctor: This devastating Covid surge didn’t need to happen
I recently came across a photo of myself in late December 2020 getting my first…
A Theranos redux & and vaccine outreach via EHRs
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
Pharmalittle: New wave of employer Covid-vaccine mandates expected; drug makers and FDA agree on new programs for rare-disease drugs
Good morning! This is Lev Facher, subbing today for Ed Silverman. I’d be remiss not…
Opinion: As Delta spreads, it’s time to put children’s health first
As pediatricians, we are committed to putting children’s health first. Last year, though, when hospitals…
Opinion: STAT+: Bringing clarity and consistency to CMS’s hospital price transparency rule will be a win for all
The Centers for Medicare and Medicaid Services’ (CMS) price transparency rule requiring U.S. hospitals to…
STAT+: Will breaking apart Google’s health bets give them a better shot at success?
Google is once again overhauling its ambitious health efforts. But this time around, some experts…
To boost Covid-19 vaccine uptake, one health system hunts for patients who fell through the cracks
As public health leaders double down on their efforts to get shots to the 30%…
STAT+: Elizabeth Holmes will be on trial. But the evidence will expose a bigger collision between tech culture and health care
When the long-awaited trial of former Theranos CEO Elizabeth Homes opens at the end of…
STAT+: STAT+ Conversation: Covid in the classroom: Keeping your kids safe
Editor’s note: A livestream of the conversation will be embedded below at 1 p.m. ET….
STAT+: FDA, drug makers propose new pilots aimed at speeding rare disease drugs, as part of user fee update
WASHINGTON — The Food and Drug Administration and the drug industry have jointly agreed to…
Opinion: FDA’s kratom ban would harm the public and damage the agency’s credibility
Trust in the U.S. Food and Drug Administration (FDA) declined after its approval of the…
Can parents handle finding out their newborn is at higher risk of certain diseases? A small study suggests they can
There’s a heated debate over whether to expand genomic sequencing to more newborns — especially…
FDA grants full approval to Covid-19 vaccine developed by Pfizer, BioNTech
The Food and Drug Administration on Monday granted full approval to the Covid-19 vaccine developed…
STAT+: Four takeaways on Pfizer’s $2.3 billion purchase of Trillium
Pfizer said Monday that it is buying Trillium, a Toronto developer of cancer drugs with…
STAT+: Pharmalittle: Pfizer to buy Trillium in $2.3 billion deal; Israel data find additional vaccine dose lowers Covid risk
Good morning everyone, hope you’re savoring the fresh start that comes with the beginning of…
Opinion: Accountable care organizations don’t cut costs. It’s time to stop the managed care experiment
For the last half-century, Congress has endorsed essentially the same approach to cutting health care…
Opinion: We know how to keep kids safe from Covid-19 in school. Now we need to do it
I live with someone who hasn’t been vaccinated against Covid-19. He’s my first-grader. Like all…
A lucky few seem ‘resistant’ to Covid-19. Scientists want to know why
Her husband collapsed just before reaching the top of the stairs in their small one-bedroom…
STAT+: Flagship, Orbimed, ARCH, Alta top list of high-performing biotech venture capital firms
Flagship Pioneering is on track to return its investors’ money an eye-popping 15 times over,…
.jpg)
STAT+: SENS Research Foundation removes Aubrey de Grey over concerns he was interfering in sexual harassment investigation
Antiaging science’s most prominent prophet, Aubrey de Grey, has been removed from his post as…
Opinion: Delay of British chronic fatigue syndrome guidelines are a setback for people with long Covid
The National Institute for Health and Care Excellence (NICE), a British agency charged with developing…
STAT+: Biotech founder David Sabatini placed on leave following investigation into sexual harassment
A prominent biology professor and biotech founder at the Massachusetts Institute of Technology has been…
Opinion: Covid-19 booster shot distribution must learn from vaccine roll-out mistakes
With news that Covid-19 booster shots are in Americans’ imminent future, the chaos and uncertainty…
STAT+: Pharmalittle: Biden reportedly rules out Woodcock as FDA commish; J&J’s Gorsky is stepping aside as CEO
And so, another working week will soon draw to a close. Not a moment too…
Kindergarten or ‘Russian roulette’? To some parents, the Delta variant and lax mask rules make those one and the same
Her daughter just started kindergarten. Or, as she called it, “Russian roulette.” That’s because the…
Opinion: Look to nurses to help accelerate the transformation of health care
The chaos and crisis of the Covid-19 pandemic have forced remarkable transformations in the U.S….
Opinion: That ‘damn machine’: the dark side of mechanical ventilators in the ICU
I walk in to Mr. W’s room to say hello. He is 73 years old…
Viral evolution 101: Why the coronavirus has changed as it has, and what it means going forward
It’s impossible to say how the coronavirus will continue to evolve. Those changes, after all,…
STAT+: After company protest, FDA agrees to review controversial drug to prevent premature birth
In an unexpected turn of events, the Food and Drug Administration will hold a hearing…
Feinberg to leave Google Health for Cerner
David Feinberg has left his post as the leader of Google Health for health care…
Listen: Biotech’s trust issues, overwhelmed health workers, & the nuances of insider trading
Why is the FDA so shy about rejection? How are health workers holding up in…
STAT+: A new technology, based on a quirk of evolutionary biology, may be the next big thing for CRISPR
On a chilly morning last November, Michael Segel stepped through the glass doors of the…
STAT+: Medical journal editorial writers have financial conflicts of interest, too
In the latest look at conflicts of interest in science, a new analysis found 15%…
A first-of-its-kind bet for an Alphabet spinout
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: Pharmalittle: FDA advisory panel members want negative votes to matter more; Illumina closes Grail deal despite regulatory hurdles
Good morning, folks. How are you today? Once again, sunny skies and a cool breeze…
Opinion: To vaccinate more Americans, lean into outbreaks
As the Delta variant surges across almost all states in the U.S. causing local outbreaks,…
Opinion: A natural pandemic has been terrible. A synthetic one would be even worse
In 1988, as Russian scientist Nikolai Ustinov worked in the VECTOR lab, part of a…